Details for 2016805576

Up to date per 01.04.2026

Actions

Title / Product Name

KOMBINATION AUS BCL-2-INHIBITOR UND MEK-INHIBITOR ZUR BEHANDLUNG VON KREBS

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2016805576

EP Publication Number

3370775

E-Number

1560700

Language

PCT Number

US16060271

Publication Date

12.09.2018 A

19.04.2023 B1

Registration Date

19.04.2023

AT Publication Date

15.05.2023

Application Date

03.11.2016

Registration Number

Priorities

03.11.2015

201562250231 P

04.12.2015

201562263082 P

IPC

A61K 31/4523 20060101AFI20211029BHEP

Maximum Duration of Protection

03.11.2036

Owner

Genentech, Inc.1 DNA Way South San Francisco, CA 94080US

Board of Regents, The University of Texas System201 West 7th Street Austin, TX 78701US

Representative

No representatives present

Inventor

MERCHANT, MarkGenentech Inc. 1 DNA Way South San Francisco, California 94080US

SAMPATH, DeepakGenentech Inc. 1 DNA Way South San Francisco, California 94080US

KONOPLEVA, Marina YurievnaM.D. Anderson Cancer Center 1515 Holcombe Blvd. Houston, Texas 77030US

HAN, LinaM.D. Anderson Cancer Center 1515 Holcombe Blvd. Houston, Texas 77030US